Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06382688
NA

IV Administration of ChromaDex's Niagen® as Compared to NAD+

Sponsor: Nutraceuticals Research Institute

View on ClinicalTrials.gov

Summary

This is a 2-part study evaluating the effects of IV administration of NR on healthy adult populations. Study 1 involved all four arms with 37 people. The second study only included the active NR and NAD+ arms to further evaluate tolerability and comfort of the IV.

Official title: The Effects of IV Administration of ChromaDex's Niagen®, Nicotinamide Riboside Chloride as Compared to IV Administration of NAD+: A Randomized, Placebo Controlled Clinical Trial

Key Details

Gender

All

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

53

Start Date

2023-11-13

Completion Date

2024-08-31

Last Updated

2024-04-24

Healthy Volunteers

Yes

Conditions

Interventions

DIETARY_SUPPLEMENT

NAD+ (nicotinamide adenine dinucleotide) IV

NAD+ enables cells to generate cellular energy from the food that one eats

DIETARY_SUPPLEMENT

Niagen® (nicotinamide riboside) IV

NR is a unique member of the vitamin B3 family. Cells can use NR to create nicotinamide adenine dinucleotide (NAD+), which is an essential molecule found in every living cell. Patients in this arm received an IV administration.

DIETARY_SUPPLEMENT

Niagen® (nicotinamide riboside) oral

NR is a unique member of the vitamin B3 family. Cells can use NR to create nicotinamide adenine dinucleotide (NAD+), which is an essential molecule found in every living cell. Patients in this arm received an oral administration.

OTHER

Placebo

These individuals received a saline IV

Locations (1)

Nutraceuticals Research Institute

Franklin, Tennessee, United States